Intellectual Property, Pharmaceuticals and Public Health

Edited by Kenneth C. Shadlen, Samira Guennif (), Alenka Guzmán and Narayanan Lalitha

in Books from Edward Elgar Publishing

Abstract: This up-to-date book examines pharmaceutical development, access to medicines, and the protection of public health in the context of two fundamental changes that the global political economy has undergone since the 1970s, the globalization of trade and production and the increased harmonization of national regulations on intellectual property rights.

Keywords: Development Studies; Economics and Finance; Law - Academic; Politics and Public Policy Social Policy and Sociology (search for similar items in EconPapers)
JEL-codes: B5 E12 (search for similar items in EconPapers)
Date: 2011
ISBN: 9781849800143
References: Add references at CitEc
Citations: View citations in EconPapers (4)

Downloads: (external link)
https://www.elgaronline.com/view/9781849800143.xml (application/pdf)
Our link check indicates that this URL is bad, the error code is: 503 Service Temporarily Unavailable

Chapters in this book:

Ch 1 Globalization, Intellectual Property Rights, and Pharmaceuticals: Meeting the Challenges to Addressing Health Gaps in the New International Environment

Kenneth C. Shadlen, Samira Guennif, Alenka Guzmán and N. Lalitha

Ch 2 Pharmaceutical Production and Access to Essential Medicines in South Africa

Heinz Klug

Ch 3 Intellectual Property and Access to Medicines: Paradoxes in Moroccan Policy

Gaelle Krikorian

Ch 4 The Invisible Threat: Trade, Intellectual Property, and Pharmaceutical Regulations in Colombia

Tatiana Andia

Ch 5 The Challenges of Constructing Pharmaceutical Capabilities and Promoting Access to Medicines in Mexico under TRIPS

Alenka Guzmán

Ch 6 Corporate Power and State Resistance: Brazil’s Use of TRIPS Flexibilities for its National AIDS Program

Matthew Flynn

Ch 7 The Politics of Patents and Drugs in Brazil and Mexico: The Industrial Bases of Health Policies

Kenneth C. Shadlen

Ch 8 Pharmaceutical Patent Policy in Developing Countries: Learning from the Canadian Experience

Jean-Frédéric Morin and Mélanie Bourassa Forcier

Ch 9 Access to Indian Generic Drugs: Emerging Issues

N. Lalitha

Ch 10 Sufficient but Expensive Drugs: A Double-Track System that Facilitated Supply Capability in China

Mariko Watanabe and Luwen Shi

Ch 11 Access to Essential Drugs in Thailand: Intellectual Property Rights and Other Institutional Matters Affecting Public Health in a Developing Country

Samira Guennif

Ch 12 The TRIPS Agreement and Health Innovation in Bangladesh

Padmashree Gehl Sampath

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:elg:eebook:13876

Ordering information: This item can be ordered from
http://www.e-elgar.com

Access Statistics for this book

More books in Books from Edward Elgar Publishing
Bibliographic data for series maintained by Darrel McCalla ().